Skip to main content

Comparative Anti-Cancer Properties of Quantum Dots and Gold Particles Conjugated to Chemotherapeutic Agents

Buy Article:

$107.14 + tax (Refund Policy)

Nanoparticles are being increasingly used as delivery vehicles for anti-cancer drugs. They improve drug delivery to and retention in tumors, decrease damage to normal tissues, and may provide active anti-tumor effects due to photosensitization or radiosensitization. However, the optimal methods of synthesis, conjugation, and delivery of anti-cancer nanoparticles remain to be determined. Their precise mechanisms of anti-cancer activity are not fully understood, and the advantages of active over passive targeting have not been established. Furthermore, there are essentially no studies that directly compare different types of nanoparticles for anti-cancer efficacy. In this chapter we review the literature on the use of two common types of nanoparticles, gold nanoparticles and quantum dots, for anti-cancer applications. The properties of cadmium-free indium phosphide (InP) quantum dots are discussed. We then present some original data directly comparing the efficacy of gold versus InP conjugates to the chemotherapeutic drug doxorubicin, using doxorubicin-resistant B16 melanoma cells as a target.

Keywords: B16; CHEMOTHERAPEUTIC; DOXORUBICIN; INP; MELANOMA; NANOPARTICLE; PHOTOSENSITIZER; QUANTUM DOT

Document Type: Review Article

Publication date: 01 February 2013

More about this publication?
  • Reviews in Nanoscience and Nanotechnology (RNN) is a multidisciplinary peer-reviewed journal covering fundamental and applied research in all disciplines of science, engineering and medicine. RNN publishes comprehensive reviews articles on all aspects of nanoscale science and technology dealing with materials synthesis, nanochemistry, processing, nanofabrication, nanoprobes, spectroscopy, properties, fullerenes, nanocomposites, theoretical and computational nanotechnology, nanophysics, nanoengineering, nanoelectronics, nano-optics, nano-mechanics, nanomagnetics, nanodevices, biological systems, nanobiotechnology, nanomedicine, drug delivery, nanotoxicology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content